
Beskrivelse
Tackling antimicrobial resistance (AMR) requires international collaboration to preserve the effectiveness of existing treatments and develop new, affordable, and accessible solutions.
In September, the Novo Nordisk Foundation and Healthcare Denmark hosted a High-Level Reception with Denmark In New York, bringing together key global stakeholders.